LONG-TERM COST-EFFECTIVENESS OF VALBENAZINE AND DEUTETRABENAZINE FOR TARDIVE DYSKINESIA

被引：1
|
作者：
Harrigan, K. [1 ]
Walton, S. M. [1 ]
Huang, S. P. [1 ]
Kumar, V. M. [2 ]
Chapman, R. H. [2 ]
Atlas, S. J. [3 ]
Agboola, F. O. [2 ]
Ollendorf, D. A. [2 ]
Touchette, D. R. [1 ]
机构：
[1] Univ Illinois, Coll Pharm, Chicago, IL USA
[2] Inst Clin & Econ Review, Boston, MA USA
[3] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1257
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH29
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [31] CLINICAL EFFICACY OF VALBENAZINE AND DEUTETRABENAZINE FOR THE TREATMENT OF TARDIVE DYSKINESIA: INDIRECT TREATMENT COMPARISON OF RANDOMIZED CONTROLLED TRIALS
    Aggarwal, S.
    Serbin, M.
    Yonan, C.
    [J]. VALUE IN HEALTH, 2019, 22 : S272 - S272
  • [32] EVALUATION OF GLOBAL IMPROVEMENT AND LIFETIME COSTS OF TREATING TARDIVE DYSKINESIA SHOWS TREATMENT WITH VALBENAZINE DOMINATES DEUTETRABENAZINE
    Ganz, M.
    Stern, S.
    Chavan, A.
    Serbin, M.
    Yonan, C.
    [J]. VALUE IN HEALTH, 2019, 22 : S275 - S275
  • [33] Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use
    Hauser, Robert A.
    Barkay, Hadas
    Fernandez, Hubert H.
    Jimenez-Shahed, Joohi
    Factor, Stewart A.
    Gross, Nicholas
    Marinelli, Leslie
    Gordon, Mark Forrest
    Barash, Steve
    Finkbeiner, Stacy
    Chaijale, Nayla
    Anderson, Karen E.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (04) : 386 - 396
  • [34] Patterns of Improvement in Tardive Dyskinesia: Post-Hoc Analysis of a Long-Term Study with Valbenazine (KINECT 4)
    Correll, Christoph U.
    Carmack, Tara
    Shah, Chirag
    Lundt, Leslie
    [J]. ANNALS OF NEUROLOGY, 2021, 90 : S148 - S149
  • [35] Effects of Long-Term Valbenazine on Tardive Dyskinesia by Body Region: Shift Analyses of KINECT 4 Study Results
    Comella, C.
    Singer, C.
    Marder, S.
    Burke, J.
    Farahmand, K.
    Jimenez, R.
    Siegert, S.
    [J]. MOVEMENT DISORDERS, 2018, 33 : S37 - S37
  • [36] TARDIVE-DYSKINESIA AND THE LONG-TERM PATIENT
    SCHWARTZ, HJ
    [J]. HOSPITAL AND COMMUNITY PSYCHIATRY, 1979, 30 (07): : 465 - 467
  • [37] LONG-TERM TREATMENT OF TARDIVE-DYSKINESIA
    JUS, A
    JUS, K
    FONTAINE, P
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1979, 40 (02) : 72 - 77
  • [38] EFFECTIVENESS OF VITAMIN-E FOR TREATMENT OF LONG-TERM TARDIVE-DYSKINESIA
    DABIRI, LM
    PASTA, D
    DARBY, JK
    MOSBACHER, D
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1994, 151 (06): : 925 - 926
  • [39] Effects of Long-Term Valbenazine on Tardive Dyskinesia and Patient-Reported Outcomes: Results from the KINECT 4 Study
    Factor, Stewart
    Kane, John
    Marder, Stephen
    Hauser, Robert
    Farahmand, Khodayar
    Jimenez, Roland
    Burke, Joshua
    Siegert, Scott
    Liang, Grace
    [J]. NEUROLOGY, 2018, 90
  • [40] Treatment Success and Psychiatric Stability in Adults With Tardive Dyskinesia: Post Hoc Analyses of Two Long-Term Valbenazine Studies
    Cutler, Andrew J.
    Jain, Rakesh
    Bloom, Alon
    Siegert, Scott
    Lundt, Leslie
    [J]. CNS SPECTRUMS, 2023, 28 (02) : 216 - 217
12345